Bryce Point Capital, LLC Roivant Sciences Ltd. Transaction History
Bryce Point Capital, LLC
- $133 Billion
- Q1 2025
A detailed history of Bryce Point Capital, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 75,267 shares of ROIV stock, worth $865,570. This represents 0.59% of its overall portfolio holdings.
Number of Shares
75,267
Previous 96,550
22.04%
Holding current value
$865,570
Previous $1.14 Billion
30.88%
% of portfolio
0.59%
Previous 0.33%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$757 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$711 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$529 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$469 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$413 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.1B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...